1. Home
  2. LIEN vs LFVN Comparison

LIEN vs LFVN Comparison

Compare LIEN & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIEN
  • LFVN
  • Stock Information
  • Founded
  • LIEN 2021
  • LFVN N/A
  • Country
  • LIEN United States
  • LFVN United States
  • Employees
  • LIEN N/A
  • LFVN N/A
  • Industry
  • LIEN
  • LFVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIEN
  • LFVN Health Care
  • Exchange
  • LIEN NYSE
  • LFVN Nasdaq
  • Market Cap
  • LIEN 234.6M
  • LFVN N/A
  • IPO Year
  • LIEN 2022
  • LFVN N/A
  • Fundamental
  • Price
  • LIEN $10.10
  • LFVN $11.88
  • Analyst Decision
  • LIEN Hold
  • LFVN Strong Buy
  • Analyst Count
  • LIEN 1
  • LFVN 2
  • Target Price
  • LIEN N/A
  • LFVN $30.50
  • AVG Volume (30 Days)
  • LIEN 16.8K
  • LFVN 222.2K
  • Earning Date
  • LIEN 05-14-2025
  • LFVN 05-06-2025
  • Dividend Yield
  • LIEN 13.59%
  • LFVN 1.35%
  • EPS Growth
  • LIEN N/A
  • LFVN 152.87
  • EPS
  • LIEN 0.93
  • LFVN 0.70
  • Revenue
  • LIEN $21,665,753.00
  • LFVN $222,347,000.00
  • Revenue This Year
  • LIEN $102.44
  • LFVN $22.17
  • Revenue Next Year
  • LIEN N/A
  • LFVN $8.73
  • P/E Ratio
  • LIEN $10.77
  • LFVN $16.95
  • Revenue Growth
  • LIEN 81.56
  • LFVN 8.22
  • 52 Week Low
  • LIEN $9.71
  • LFVN $5.22
  • 52 Week High
  • LIEN $13.38
  • LFVN $27.38
  • Technical
  • Relative Strength Index (RSI)
  • LIEN N/A
  • LFVN 38.88
  • Support Level
  • LIEN N/A
  • LFVN $9.83
  • Resistance Level
  • LIEN N/A
  • LFVN $12.22
  • Average True Range (ATR)
  • LIEN 0.00
  • LFVN 0.98
  • MACD
  • LIEN 0.00
  • LFVN 0.02
  • Stochastic Oscillator
  • LIEN 0.00
  • LFVN 51.93

About LIEN CHICAGO ATLANTIC BDC INC

Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.

Share on Social Networks: